Noul Co.,Ltd. (KOSDAQ:376930)
South Korea · Delayed Price · Currency is KRW 1,756.00
+17.00 (0.98%)
At close: Apr 20, 2026
Noul Co.,Ltd. Revenue
In the year 2025, Noul Co.,Ltd. had annual revenue of 5.12B KRW with 219.83% growth. Noul Co.,Ltd. had revenue of 1.24B in the quarter ending December 31, 2025, with 3,167.20% growth.
Revenue
5.12B
Revenue Growth
+219.83%
P/S Ratio
17.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
87.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.12B | 3.52B | 219.83% |
| Dec 31, 2024 | 1.60B | -1.13B | -41.42% |
| Dec 31, 2023 | 2.73B | 2.19B | 404.51% |
| Dec 31, 2022 | 541.88M | -933.43M | -63.27% |
| Dec 31, 2021 | 1.48B | 1.18B | 399.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 102.75B |
| JPI Healthcare | 48.47B |
| L&K Biomed | 38.92B |
| Hironic | 32.09B |
| SELVAS Healthcare | 30.82B |
| Remed | 24.50B |
| Neofect | 16.05B |